Centene Slashes 2026 Medicaid Outlook, Membership to Drop 8-9% on Work Rules
CNC has more than doubled off its 52-week low of $25.075.
Summary
Centene cut its 2026 Medicaid outlook, forecasting an 8-9% membership decline due to work-rule impacts, and vowed to restore profitability in the segment. Shares fell about 6% in early trading. The company also announced the redemption of $500M in 4.25% notes due 2027 and added Paul Diaz to its board. This follows a strong Q2 report last week that beat estimates and raised guidance, but the Medicaid headwind overshadows those results. The note redemption is a routine capital move, but the board addition brings healthcare CEO experience. The Medicaid outlook cut is the key negative — it signals ongoing enrollment pressure from policy changes.
At the time of this announcement, CNC was trading at $62.46 on NYSE in the Life Sciences sector, with a market capitalization of approximately $30.7B. The 52-week trading range was $25.08 to $69.36. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Wiseek News.